Ginsenoside Metabolite Compound K Alleviates Adjuvant-Induced Arthritis by Suppressing T Cell Activation
- 582 Downloads
Ginsenoside metabolite compound K (CK) is the degradation product of ginsenosides in the intestine by bacteria and has many pharmacological activities including anti-inflammatory effects. Rheumatoid arthritis (RA) is an inflammatory and autoimmune disease characterized by chronic synovial inflammation and articular damage in multiple joints. However, the effect of CK on RA remains unclear. In this study, the effect of CK on adjuvant arthritis (AA) and the underlying mechanisms that focused on T cell activation were investigated. Complete Freund’s adjuvant was used to induce AA rats. After the onset of arthritis, rats were given CK (10, 40, and 160 mg/kg) or MTX (0.5 mg/kg). To evaluate the severity of arthritis, arthritis index and paw swelling were evaluated every 3 days. Histopathology of joint and spleen were assayed. Subsets of T cells including CD4 + CD62L+ (naïve T cells), CD4 + CD25+ (activated T cells), and CD4 + CD25 + Foxp3+ cells (Treg) and CD25 expression were assayed by flow cytometry. Proliferation of T cell was evaluated by 3H-TdR. IL-2 level was assayed by ELISA. We found that CK attenuated arthritis index and paw swelling, restored the histopathological change of joint and spleen, downregulated the percentage of activated T cells, and upregulated naïve T cells and Treg cells in spleen. CK significantly suppressed T cell activation (as indicated by T cell proliferation, CD25 expression, and IL-2 production). In conclusion, our results suggest that CK alleviates autoimmune arthritis by suppressing T cell activation.
KEY WORDSginsenoside metabolite compound K adjuvant-induced arthritis T cell activation CD25 IL-2 regulatory T cells
This work was financially supported by the National Nature Science Foundation of China (Nos. 30973543, 81173075, 81330081, and 31200675), Anhui Province Nature Science Foundation in the University (No. KJ2011Z180), Foundation for Outstanding Young Talents in Higher Education Institutions of Anhui Province (No. 2012SQRL268), and Anhui Provincial Natural Science Foundation (No. 1208085QH158).
Conflict of Interest
The authors declare that there are no conflicts of interest.
- 6.Chang, Y., Y. Wu, D. Wang, W. Wei, Q. Qin, G. Xie, L. Zhang, S. Yan, J. Chen, Q. Wang, H. Wu, F. Xiao, W. Sun, J. Jin, and W. Wang. 2011. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology (Oxford) 50(5): 862–870.CrossRefGoogle Scholar
- 7.Song, S.S., B. Huang, Q.T. Wang, Y.J. Wu, J.J. Fu, Y.F. Zhang, Y. Chang, J.Y. Chen, H.X. Wu, D. Wang, L.L. Zhang, and W. Wei. 2013. BF02, a recombinant TNFR2 fusion protein, alleviates adjuvant arthritis by regulating T lymphocytes in rats. Acta Pharmacologica Sinica 34(3): 414–423.PubMedCrossRefPubMedCentralGoogle Scholar
- 11.Park, E.K., Y.W. Shin, H.U. Lee, S.S. Kim, Y.C. Lee, B.Y. Lee, and D.H. Kim. 2005. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biological and Pharmaceutical Bulletin 28(4): 652–656.PubMedCrossRefGoogle Scholar
- 12.Yang, C.S., S.R. Ko, B.G. Cho, D.M. Shin, J.M. Yuk, S. Li, J.M. Kim, R.M. Evans, J.S. Jung, D.K. Song, and E.K. Jo. 2008. The ginsenoside metabolite compound K, a novel agonist of glucocorticoid receptor, induces tolerance to endotoxin-induced lethal shock. Journal of Cellular and Molecular Medicine 12(5A): 1739–1753.PubMedCrossRefGoogle Scholar
- 16.Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H.A. Young, J. Hu-Li, J. Zhu, and W.E. Paul. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proceedings of the National Academy of Sciences of the United States of America 101(11): 3880–3885.PubMedCrossRefPubMedCentralGoogle Scholar
- 20.Brok, H.P., J.M. Tekoppele, J. Hakimi, J.A. Kerwin, E.M. Nijenhuis, C.W. De Groot, R.E. Bontrop, and B.A. ‘t Hart. 2001. Prophylactic and therapeutic effects of a humanized monoclonal antibody against the IL-2 receptor (DACLIZUMAB) on collagen-induced arthritis (CIA) in rhesus monkeys. Clinical and Experimental Immunology 124(1): 134–141.PubMedCrossRefPubMedCentralGoogle Scholar
- 24.Frey, O., P.K. Petrow, M. Gajda, K. Siegmund, J. Huehn, A. Scheffold, A. Hamann, A. Radbruch, and R. Bräuer. 2005. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Research and Therapy 7(2): R291–R301.PubMedCrossRefPubMedCentralGoogle Scholar
- 25.Kong, N., Q. Lan, M. Chen, T. Zheng, W. Su, J. Wang, Z. Yang, R. Park, G. Dagliyan, P.S. Conti, D. Brand, Z. Liu, H. Zou, W. Stohl, and S.G. Zheng. 2012. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Annals of the Rheumatic Diseases 71(9): 1567–1572.PubMedCrossRefPubMedCentralGoogle Scholar
- 28.Wu, H., J. Chen, Q. Wang, X. Jia, S. Song, P. Yuan, K. Liu, L. Liu, Y. Zhang, A. Zhou, and W. Wei. 2014. Ginsenoside metabolite compound K attenuates inflammatory responses of adjuvant-induced arthritis rats. Immunopharmacology and Immunotoxicology Google Scholar